[PERSON]

Wegovy (semaglutide)

Featured in 2 tracked stories · first seen 6 days ago

Situations

[ACTIVE] [HEALTH] [BUSINESS] [CRIME] [US] [BR] [GB]

GLP‑1 weight‑loss drugs: safety, policy and clinical rollout

188 clusters · 689 sources · last updated 1 day ago

Latest: Anvisa bans unregistered weight‑loss products while planning approval of eight new GLP‑1 pens

Since mid‑2026, the rapid expansion of GLP‑1 agents for obesity has been accompanied by growing emphasis on complementary diet, insurance constraints and emerging safety signals. Clinical experts in the United States and

[ACTIVE] [HEALTH] [DK] [US]

GLP-1 drugs: therapeutic and economic impacts

2 clusters · 16 sources · last updated 6 days ago

Latest: GLP-1 drugs Ozempic and Wegovy cut employee sick leave by 17%

Researchers are exploring GLP‑1 medications such as Ozempic, Wegovy and Zepbound for their potential to slow biological aging, noting that these drugs affect several hallmarks of aging and could become the first approved